Analysis of the clinical effect of ambroxol hydrochloride on the treatment of COVID-19
L Li, Z Xin, ZH Dai Muwei, K Haiyan, X Yi… - Electronic Journal of …, 2022 - xfcrb2020.com
Objective To observe the clinical efficacy and safety of ambroxol hydrochloride on the
treatment of Coronavirus disease 2019 (COVID-19). Method A total of 68 patients with …
treatment of Coronavirus disease 2019 (COVID-19). Method A total of 68 patients with …
[PDF][PDF] Geneticin shows selective antiviral activity against SARS-CoV-2 by targeting programmed-1 ribosomal frameshifting
C Varricchio1Ϯ, G Mathez, L Kaiser, C Tapparel… - scienceopen.com
ABSTRACT SARS-CoV-2 is currently causing an unprecedented pandemic. While vaccines
are massively deployed, we still lack effective large-scale antiviral therapies. In the quest for …
are massively deployed, we still lack effective large-scale antiviral therapies. In the quest for …
Neuraminidase-Inhibited Influenza Virus
US Patent App. 18/470,999, 2024 - Google Patents
A composition, method of making, and method of using an active agent against a myriad of
known as well as unknown pathogens comprising: binding a live influenza virus with a …
known as well as unknown pathogens comprising: binding a live influenza virus with a …